Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Avril

Showing results (51-60 of 199) with videos related to

Pageof 20
Sort By:
The Journal of Investigative Dermatology|September 1, 1991
Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cellsO Azogui, M F Avril, A Margulis, et al.
Cancer Research|October 10, 1998
p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group CG Giglia, N Dumaz, C Drougard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2012
Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathwayM P Rodero, A Prignon, M F Avril, et al.
The British Journal of Dermatology|August 6, 2013
Acute kidney injury in patients with severe rash on vemurafenib treatment for metastatic melanomasE Regnier-Rosencher, H Lazareth, L Gressier, et al.
Dermatology (Basel, Switzerland)|October 12, 2011
Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature reviewF Brunet-Possenti, N Franck, J Tamburini, et al.
Journal of the American Academy of Dermatology|February 1, 1991
Primary neuroendocrine carcinoma of the skin. Clinicopathologic study of 18 casesO Bayrou, M F Avril, P Charpentier, et al.
The British Journal of Dermatology|May 31, 2008
Ultraviolet responses of Gorlin syndrome primary skin cellsF Brellier, A Valin, O Chevallier-Lagente, et al.
Genetic Epidemiology|January 1, 1996
Genetic and epidemiological risk factors for a malignant melanoma-predisposing phenotype: the great number of neviL Briollais, A Chompret, M Guilloud-Bataille, et al.
Melanoma Research|September 1, 1992
Fotemustine: an overview of its clinical activity in disseminated malignant melanomaD Khayat, M F Avril, B Gerard, et al.
The British Journal of Dermatology|October 20, 2015
First-line treatment with paclitaxel for non-HIV-related Kaposi sarcoma: experience in 10 casesD Denis, E Régnier-Rosencher, N Kramkimel, et al.
Pageof 20

Showing results (51-60 of 199) with videos related to

Sort By:
Pageof 20
The Journal of Investigative Dermatology|September 1, 1991
Tumor-infiltrating CD3- NK cells are more effective than CD3+ T cells in killing autologous melanoma cellsO Azogui, M F Avril, A Margulis, et al.
Cancer Research|October 10, 1998
p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group CG Giglia, N Dumaz, C Drougard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 3, 2012
Increase lymphangiogenesis in melanoma during pregnancy: correlation with the prolactin signalling pathwayM P Rodero, A Prignon, M F Avril, et al.
The British Journal of Dermatology|August 6, 2013
Acute kidney injury in patients with severe rash on vemurafenib treatment for metastatic melanomasE Regnier-Rosencher, H Lazareth, L Gressier, et al.
Dermatology (Basel, Switzerland)|October 12, 2011
Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature reviewF Brunet-Possenti, N Franck, J Tamburini, et al.
Journal of the American Academy of Dermatology|February 1, 1991
Primary neuroendocrine carcinoma of the skin. Clinicopathologic study of 18 casesO Bayrou, M F Avril, P Charpentier, et al.
The British Journal of Dermatology|May 31, 2008
Ultraviolet responses of Gorlin syndrome primary skin cellsF Brellier, A Valin, O Chevallier-Lagente, et al.
Genetic Epidemiology|January 1, 1996
Genetic and epidemiological risk factors for a malignant melanoma-predisposing phenotype: the great number of neviL Briollais, A Chompret, M Guilloud-Bataille, et al.
Melanoma Research|September 1, 1992
Fotemustine: an overview of its clinical activity in disseminated malignant melanomaD Khayat, M F Avril, B Gerard, et al.
The British Journal of Dermatology|October 20, 2015
First-line treatment with paclitaxel for non-HIV-related Kaposi sarcoma: experience in 10 casesD Denis, E Régnier-Rosencher, N Kramkimel, et al.
Pageof 20